The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...

The AGBT meeting has begun in Marco Island, Florida and Julianna LeMieux is on the ground. Here, she shares the latest news ...

Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...

AI tool uses MRI scans to track the pace of brain changes, mapping anatomic variations in regional brain aging rates according to factors including sex and age.

Researchers say understanding how Zika virus spreads through the human placenta and reaches the fetus is critical to prevent ...

Roche introduces Sequencing by Expansion (SBX) technology in a webinar just a few days before the AGBT meeting takes place in ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Some of the funds will be used to develop multiomics solutions based on Atrandi's proprietary technology for single-cell ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Running a multi-product facility requires expertise. And, while technology is important, human expertise remains the most ...

Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).

The research advance represents a 1,000-fold improvement in speed and throughput in Brillouin microscopy, according to the ...